Spinal Modulation

Spinal Modulation

Pioneering a new era in pain management, offering targeted relief through advanced neuromodulation therapy.

Founded 2004 Series E Total: $111.27M Health Care, Medical Devices

Spinal Modulation, Inc., a California-based medical device company, is pioneering a new era in pain management, offering targeted relief through advanced neuromodulation therapy. As per the 2002 Health Assessment on the Prevalence of Chronic Pain, severe chronic pain affects 10 to 13% of the adult population, placing a substantial burden on the healthcare system due to limited treatment options. The company's flagship product, the Spinal Modulation Axium Neurostimulator System, is an advanced intraspinal neuromodulation therapy designed to stimulate the dorsal root ganglion (DRG) for effective pain management. This innovative system has shown success in treating chronic intractable leg pain, as well as challenging pain areas such as the back and foot. One of the key advantages of this therapy is its ability to target the DRG, allowing for fine-tuning to address broad or specific pain regions in the torso and legs, while minimizing the uncomfortable postural effects often associated with other spinal cord stimulators. Spinal Modulation secured a $45.00M Series E investment from St. Jude Medical on 07 June 2013. This funding reflects investor confidence in the company's potential to address an unmet need in the field of pain management. With its innovative approach and demonstrated success, Spinal Modulation is well-positioned to make a meaningful impact in the health care and medical devices industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Series E	$45.00M	1	St. Jude Medical	07 Jun 2013
Debt Financing	$1.87M	1	Halo Fund	05 Mar 2013
Series D	$30.00M	8	Kleiner Perkins, DeNovo Ventures +6	15 Jun 2011
Series C	$27.40M	-		09 Nov 2009
Series A	$7.00M	-		24 Jan 2006

Funding Stage

Amount

Investors

Lead Investors

Date

Series E

$45.00M

St. Jude Medical

07 Jun 2013

Debt Financing

$1.87M

Halo Fund

05 Mar 2013

Series D

$30.00M

Kleiner Perkins, DeNovo Ventures +6

15 Jun 2011

Series C

$27.40M

09 Nov 2009

Series A

$7.00M

24 Jan 2006

FAQ About Spinal Modulation

Pioneering a new era in pain management, offering targeted relief through advanced neuromodulation therapy.

Spinal Modulation was founded in 2004.

Spinal Modulation operates in Health Care and Medical Devices. Its work centres on neuromodulation therapy, pain management, Spinal Modulation Axium Neurostimulator System and dorsal root ganglion (DRG).

Spinal Modulation has completed 5 funding rounds, raising a total of $111.27M. The latest funding stage is Series E.

Top alternatives and competitors to Spinal Modulation include Valencia Technologies, Saluda Medical, PainTEQ, Palyon Medical Corporation, CorTec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Spinal Modulation and Valencia Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Spinal Modulation

Funding Rounds & Investors (5)

Spinal Modulation Alternatives & Competitors

FAQ About Spinal Modulation